These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8608788)

  • 1. Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling.
    Croucher MJ; Cotterell KL; Bradford HF
    Eur J Pharmacol; 1995 Nov; 286(3):265-71. PubMed ID: 8608788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of focal N-methyl-D-aspartate pretreatment on the parameters of amygdaloid electrical kindling.
    Croucher MJ; Ruffle KL; Bradford HF
    Eur J Pharmacol; 1997 Jan; 319(2-3):207-13. PubMed ID: 9042592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMDA receptor blockade inhibits glutamate-induced kindling of the rat amygdala.
    Croucher MJ; Bradford HF
    Brain Res; 1990 Jan; 506(2):349-52. PubMed ID: 1967970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of N-methyl-D-aspartate (NMDA)-induced kindling.
    Croucher MJ; Cotterell KL; Bradford HF
    Biochem Soc Trans; 1996 May; 24(2):295S. PubMed ID: 8736953
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats.
    Wlaź P; Ebert U; Löscher W
    Neuropharmacology; 1999 Feb; 38(2):243-51. PubMed ID: 10218865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intrahippocampal quinolinic acid infusion on the amygdala kindling in rat.
    Ping HX; Liu GQ; Xie L; Wu HQ
    Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):304-7. PubMed ID: 1807077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
    Wlaź P; Ebert U; Potschka H; Löscher W
    Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1993 Apr; 234(2-3):237-45. PubMed ID: 8097722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-epileptic effect of 3-aminopropylarsonate on electrically-kindled and N-methyl-D-aspartate-kindled amygdala.
    Abdul-Ghani AS; Attwell PJ; Bradford HF
    Brain Res; 1996 Dec; 742(1-2):305-12. PubMed ID: 9117409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.
    Dürmüller N; Craggs M; Meldrum BS
    Epilepsy Res; 1994 Feb; 17(2):167-74. PubMed ID: 8194512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kindling-induced long-lasting changes in synaptic transmission in the basolateral amygdala.
    Rainnie DG; Asprodini EK; Shinnick-Gallagher P
    J Neurophysiol; 1992 Feb; 67(2):443-54. PubMed ID: 1349037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive NMDA receptor antagonists do not block cholinergic kindling with carbachol.
    Saucier D; Cain DP
    Epilepsy Res; 1996 May; 24(1):9-18. PubMed ID: 8800631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retardation of amygdala kindling by antagonism of NMD-aspartate and muscarinic cholinergic receptors: evidence for the summation of excitatory mechanisms in kindling.
    Cain DP; Desborough KA; McKitrick DJ
    Exp Neurol; 1988 Apr; 100(1):179-87. PubMed ID: 2895012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of amygdaloid kindled convulsion following bilateral injection of 2-amino-7-phosphonoheptanoic acid into the substantia nigra of rats.
    Mori N; Shimoyamada K; Kumashiro H
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):462-3. PubMed ID: 2147962
    [No Abstract]   [Full Text] [Related]  

  • 18. N-methyl-D-aspartate injection into the massa intermedia facilitates development of limbic kindling in rats.
    Hirayasu Y; Wada JA
    Epilepsia; 1992; 33(6):965-70. PubMed ID: 1464279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kindling of full limbic seizures by repeated microinjections of excitatory amino acids into the rat amygdala.
    Croucher MJ; Bradford HF
    Brain Res; 1989 Oct; 501(1):58-65. PubMed ID: 2572307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of N-methyl-D-aspartate (NMDA) and its competitive antagonist, 3-(2-carboxypiperazine-4-yl)propyl-1-phosphonic acid (CPP), injected into caudate-putamen on kindled amygdaloid seizures in rats.
    Osonoe M; Mori N; Hoshino S; Yamada Y; Osonoe K; Kittaka H; Iwata Y
    Brain Res; 1996 Jul; 728(2):242-6. PubMed ID: 8864488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.